Breeman WA - Search Results

1

Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours.

Slooter GD, Mearadji A, Breeman WA, Marquet RL, de Jong M, Krenning EP, van Eijck CH. Slooter GD, et al. Among authors: breeman wa. Br J Surg. 2001 Jan;88(1):31-40. doi: 10.1046/j.1365-2168.2001.01644.x. Br J Surg. 2001. PMID: 11136306 Review.

2

The inhibitory effect of (111)In-DTPA(0)-octreotide on intrahepatic tumor growth after partial hepatectomy.

Slooter GD, Aalbers AG, Breeman WA, Hiemstra CA, Marquet RL, Krenning EP, van Eijck CH. Slooter GD, et al. Among authors: breeman wa. J Nucl Med. 2002 Dec;43(12):1681-7. J Nucl Med. 2002. PMID: 12468520 Free article.

3

Radiolabelled regulatory peptides for imaging and therapy.

Breeman WA, Kwekkeboom DJ, de Blois E, de Jong M, Visser TJ, Krenning EP. Breeman WA, et al. Anticancer Agents Med Chem. 2007 May;7(3):345-57. doi: 10.2174/187152007780618171. Anticancer Agents Med Chem. 2007. PMID: 17504160 Review.

4

Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.

Krenning EP, Bakker WH, Kooij PP, Breeman WA, Oei HY, de Jong M, Reubi JC, Visser TJ, Bruns C, Kwekkeboom DJ, et al. Krenning EP, et al. Among authors: breeman wa. J Nucl Med. 1992 May;33(5):652-8. J Nucl Med. 1992. PMID: 1349039 Free article.

5

In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats.

Bakker WH, Krenning EP, Reubi JC, Breeman WA, Setyono-Han B, de Jong M, Kooij PP, Bruns C, van Hagen PM, Marbach P, et al. Bakker WH, et al. Among authors: breeman wa. Life Sci. 1991;49(22):1593-601. doi: 10.1016/0024-3205(91)90053-e. Life Sci. 1991. PMID: 1658516

6

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, van Hagen M, Postema PT, de Jong M, Reubi JC, et al. Krenning EP, et al. Among authors: breeman wa. Eur J Nucl Med. 1993 Aug;20(8):716-31. doi: 10.1007/BF00181765. Eur J Nucl Med. 1993. PMID: 8404961 Free article. Review.

7

Iodine-131 labelled octreotide: not an option for somatostatin receptor therapy.

Bakker WH, Breeman WA, van der Pluijm ME, de Jong M, Visser TJ, Krenning EP. Bakker WH, et al. Among authors: breeman wa. Eur J Nucl Med. 1996 Jul;23(7):775-81. doi: 10.1007/BF00843706. Eur J Nucl Med. 1996. PMID: 8662116 Free article.

8

Somatostatin receptor: scintigraphy and radionuclide therapy.

Krenning EP, Kooij PP, Pauwels S, Breeman WA, Postema PT, De Herder WW, Valkema R, Kwekkeboom DJ. Krenning EP, et al. Among authors: breeman wa. Digestion. 1996;57 Suppl 1:57-61. doi: 10.1159/000201398. Digestion. 1996. PMID: 8813472 Clinical Trial.

9

Studies on radiolabeled somatostatin analogues in rats and in patients.

Breeman WA, Bakker WH, De Jong M, Hofland LJ, Kwekkeboom DJ, Kooij PP, Visser TJ, Krenning EP. Breeman WA, et al. Q J Nucl Med. 1996 Sep;40(3):209-20. Q J Nucl Med. 1996. PMID: 8961800 Review.

10

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy.

de Jong M, Bakker WH, Krenning EP, Breeman WA, van der Pluijm ME, Bernard BF, Visser TJ, Jermann E, Béhé M, Powell P, Mäcke HR. de Jong M, et al. Among authors: breeman wa. Eur J Nucl Med. 1997 Apr;24(4):368-71. doi: 10.1007/BF00881807. Eur J Nucl Med. 1997. PMID: 9096086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters